JELY PHARMA
ActiveSummary
JELY PHARMA has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €381 and a net result of €20,540. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 13% of 5,027 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.0% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
01-04
NBB filing
Annual accounts filed
financial year 2025 · full format
2025
18-08
NBB filing
Annual accounts filed
financial year 2024 · full format · 18 days late
2024
31-12
Financial
Weakest financial yearnet €15,299 ▼63.6%
Net result drops to €15,299, the lowest in the series; recovery starts the following year.
12-09
NBB filing
Annual accounts filed
financial year 2023 · full format · 43 days late
2023
29-08
NBB filing
Annual accounts filed
financial year 2022 · full format · 29 days late
2022
31-12
Financial
Highest result from 2018 to 2025net €112,018 ▲7.7%
Operating result €163,643, net result €112,018, both a record.
30-06
NBB filing
Annual accounts filed
financial year 2021 · full format
2021
04-08
NBB filing
Annual accounts filed
financial year 2020 · micro format · 4 days late
2020
30-06
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
14-08
NBB filing
Annual accounts filed
financial year 2018 · full format · 14 days late
2018
27-06
NBB filing
Annual accounts filed
financial year 2017 · full format
2017
25-08
NBB filing
Annual accounts filed
financial year 2016 · full format · 25 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 4 deeds read
About the unread acts
We know of 4 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.